Form 4: Encompass Health Director Christopher R. Reidy Reports Stock Acquisitions

Director Christopher R. Reidy reports acquisitions of Encompass Health Corp stock through dividend reinvestment and participation in the Directors Deferred Stock Investment Plan.

Summary

• Christopher R. Reidy, a director of Encompass Health Corp, filed a Form 4 detailing changes in beneficial ownership.
• On October 15, 2024, Reidy acquired 16 shares of Encompass Health common stock through dividend reinvestment at a price of $0 per share.
• On October 17, 2024, Reidy acquired 362 shares of Encompass Health common stock at $97.53 per share through the Directors Deferred Stock Investment Plan.
• Following these transactions, Reidy beneficially owns 12,241 shares of Encompass Health common stock.
• The dividend paid on October 15, 2024, was $0.17 per share, with a closing price of $96.33.
• The Directors Deferred Stock Investment Plan allows non-employee directors to defer a percentage of their director fees to purchase company stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The director is increasing their stake in the company, which is generally a good sign. The transactions are routine and expected.

Positives

• Director's participation in the Directors Deferred Stock Investment Plan demonstrates confidence in the company's future.
• Dividend reinvestment further aligns the director's interests with those of shareholders.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, ensuring fair market practices.

Comparison to Industry Standards

• Director stock ownership is a common practice across publicly traded companies.
• Deferred compensation plans for directors are also common, aligning their interests with long-term shareholder value.
• The level of stock ownership and participation in deferred compensation plans varies widely depending on the company's size, industry, and specific compensation policies.
• Comparing Reidy's holdings and participation to those of directors at comparable healthcare companies (e.g., Select Medical, LHC Group) would provide a more detailed benchmark.

Stakeholder Impact

• The director's increased stock ownership could be viewed positively by shareholders, signaling confidence in the company's prospects.

Key Dates